Olifen

Olifen is a Spanish biotechnology company specializing in the research and development of bioactive compounds derived from olives, with a primary focus on high-purity hydroxytyrosol. The company utilizes advanced extraction and stabilization techniques to develop therapeutic solutions for conditions driven by oxidative stress and chronic inflammation. Olifen's lead candidate has undergone Phase 2 clinical testing for the treatment of COVID-19, aiming to reduce inflammatory markers and prevent severe complications such as the cytokine storm. Additionally, the company targets cardiovascular health and other immune-related disorders through its portfolio of olive-derived polyphenols. Olifen aims to bridge the gap between nutraceutical science and pharmaceutical-grade clinical evidence.